Moderna has reported preliminary clinical ... if governments decide they are needed. "We believe that a bivalent booster vaccine, if authorised, would create a new tool as we continue to respond ...

This action gives people ages 18 years and older the option to receive a Novavax monovalent booster instead of an updated (bivalent) Pfizer-BioNTech or Moderna booster if they have completed ...

Moderna, meanwhile, also agreed with the EU to set back its planned deliveries so member states " will have the possibility to receive the expected updated bivalent booster candidate following ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons. Here we answer common questions about the latest ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons.

Pfizer-BioNTech, Moderna's Bivalent COVID-19 vaccines get emergency use authorisation for Omicron booster in US However, ...

On Aug. 22, the Food and Drug Administration approved and authorized newer formulations of the two mRNA vaccines, from Pfizer/BioNTech and Moderna ... “JN.1-booster vaccination significantly ...